Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
14,600,620
-
Share change
-
+1,660,145
-
Total reported value
-
$84,244,102
-
Put/Call ratio
-
19%
-
Price per share
-
$5.77
-
Number of holders
-
63
-
Value change
-
+$9,113,868
-
Number of buys
-
40
-
Number of sells
-
23
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2023
As of 30 Jun 2023,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,600,620 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.